UroSens Receives Funding and Enters into Clinical Trials
Tuesday, June 18, 2013
Board of directors strengthened with key appointments.
AMRI Promotes Susan Collins to Director, Business Development
Tuesday, June 18, 2013
Ms. Collins is responsible for leading AMRI’s North American Discovery Business Development team.
Almac Announces Further Expansion and 229 New Jobs
Monday, June 17, 2013
Dual expansion with completion of a new non-GMP drug development facility.
apceth Receives Approval for a Clinical Cancer Trial with Adult Mesenchymal Stem Cells
Friday, June 14, 2013
apceth's first innovative cellular anti-cancer drug based on modified mesenchymal stem cells enters Phase I / II of clinical testing.
Dezima Pharma Appoints Seasoned New CEO
Thursday, June 13, 2013
Appointment of Rob de Ree as Company’s new Chief Executive Officer.
Nanobiotix Receives Approval from ANSM to Start New Clinical Trial with NBTXR3
Thursday, June 13, 2013
Second indication for NanoXray product in Head and Neck cancer patients.
Launch of Innovation Division & Expansion of Business Throughout Europe
Wednesday, June 12, 2013
Venn has announced the launch of InnoVenn.
Cobra Biologics and Novolytics Develop Bacteriophages Against Infection
Wednesday, June 12, 2013
Companies have achieved a breakthrough in the development of two Staphylococcus aureus-based phage products for Phase I clinical trials.
Big Multiple Sclerosis Breakthrough
Tuesday, June 11, 2013
Phase 1 trial safely resets patients’ immune systems, reduces attack on myelin protein.
|
|
|
| << | 1 2 3 4 5 6 7 | >> | | Showing Results 1 - 10 of 2314 |
|
|
